Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women
30/06/2009 in Clinical dataHip fracture is associated with high early mortality. Little is known about long-term survival and subsequent fracture risk. The aim of this study [1] was to evaluate survival and fracture risk after hip fracture in women at different ages. All women suffering a hip fracture during 1984–1985 in Malmö, Sweden, were identified (n = 766) and followed up to 22 y or death. All new radiographic examinations related to musculoskeletal trauma with or without fracture were registered. Survival (mortality) and fracture was evaluated in 5-y age bands and in age groups (<75, 75–84, and >85 y).
Mean age was 79.6 ± 9.9 y, with 42% between 75 and 85 y of age. Overall 22-y survival was 6%: 79% at 1 y, 48% at 5 y, and 33% at 10 y (i.e., population at risk). One-year mortality was 7%, 21%, and 33% for <75, 75–84, and >85 y of age, respectively, and 95% of those >85 y were dead at 10 y. A total of 768 fractures were registered at 715 occasions in 342 women (45%; mean, 2.3 fractures/woman; range, 1–11 fractures/woman). Of the fracture occasions, 15% occurred within the first year, 27% within 2 y, and 73% within 5 y. The residual lifetime fracture risk was 45%, with a mortality-adjusted increase to 86%. The 10-y fracture risk was 40%, with a mortality-adjusted increased to 65%.
In conclusion, almost one half of all women with a hip fracture suffer a new fracture during their remaining lifetime. Fracture risk is highly dependent on age and survival, emphasizing that preventive strategies need to be tailored to each age group specifically.
- von Friesendorff M et al. J Bone Miner Res. 2008;23:1832–1841.
|
|
|



Most used keywords
β-catenin age BMD bone bone density bone density test bone formation bone fracture bone loss bone marrow bone remodeling bone resorption bone strength breast cancer calcium cardiovascular cardiovascular disease cell cell bone marrow cholesterol Clinical data diabetes disease epidemiology fracture fracture risk FRAX heart heart disease hip fracture mesenchymal stem cells neuromedin U osteoblast osteoblast differentiation osteoclast osteoporosis osteoprotegerin osterix ovariectomy RANKL residual lifetime risk risk factors sclerotin survival weight loss